{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:04:17Z","timestamp":1766361857846},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.trsl.2007.05.003","type":"journal-article","created":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T11:12:58Z","timestamp":1182942778000},"page":"275-280","source":"Crossref","is-referenced-by-count":25,"title":["Thalidomide suppressed interleukin-6 but not tumor necrosis factor-alpha in volunteers with experimental endotoxemia"],"prefix":"10.1016","volume":"150","author":[{"given":"Edward","family":"Shannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Noveck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Sandoval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Burde","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2007.05.003_bib1","first-page":"177","article-title":"Immunomodulation by thalidomide: systematic review of the literature of unpublished observations","volume":"46","author":"Zwingerberger","year":"1996","journal-title":"J Inflamm"},{"key":"10.1016\/j.trsl.2007.05.003_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/infdis\/168.2.408","article-title":"The influence of thalidomide on clinical leprosum","volume":"168","author":"Sampaio","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trsl.2007.05.003_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4269\/ajtmh.2005.72.518","article-title":"A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum","volume":"72","author":"Villahermosa","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.trsl.2007.05.003_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08923979609007110","article-title":"Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells","volume":"18","author":"Shannon","year":"1996","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"10.1016\/j.trsl.2007.05.003_bib5","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1086\/498216","article-title":"Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation","volume":"192","author":"Haslett","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.trsl.2007.05.003_bib6","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199705223362103","article-title":"Thalidomide for the treatment of oral aphthous ulcers in patients with immunodeficiency virus infection","volume":"336","author":"Jacobson","year":"1997","journal-title":"New Engl J Med"},{"key":"10.1016\/j.trsl.2007.05.003_bib7","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","article-title":"Randomized comparison of thalidomide versus placebo in toxic epidermal necrolysis","volume":"352","author":"Wolkenstein","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.trsl.2007.05.003_bib8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor \u03b1 production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.trsl.2007.05.003_bib9","first-page":"142","article-title":"Thalidomide inhibits TNF response and increases survival following endotoxin injection in rats","volume":"3","author":"Schmidt","year":"1996","journal-title":"J Surg Res"},{"key":"10.1016\/j.trsl.2007.05.003_bib10","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1590\/S0100-879X1997001000010","article-title":"Thalidomide protects mice against LPS-induced shock","volume":"30","author":"Moreira","year":"1997","journal-title":"Braz J Med Bio Res"},{"key":"10.1016\/j.trsl.2007.05.003_bib11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1248\/bpb.21.638","article-title":"Thalidomide promotes the release of tumor necrosis factor-\u03b1 (TNF-\u03b1) and lethality by lipopolysaccharide in mice","volume":"21","author":"Ishikawa","year":"1998","journal-title":"Bio Phar Bull"},{"key":"10.1016\/j.trsl.2007.05.003_bib12","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.bcp.2004.06.018","article-title":"Immunomodulatory effects of thalidomide analogs on LPS-induced plasma and hepatic cytokines in the rat","volume":"68","author":"Fernandez-Martinez","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.trsl.2007.05.003_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0065-2776(08)60597-0","article-title":"Role of cytokines in sepsis","volume":"66","author":"Hack","year":"1997","journal-title":"Adv Immunol"},{"key":"10.1016\/j.trsl.2007.05.003_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0378-4347(92)80321-G","article-title":"Determination of thalidomide in plasma by high-performance liquid chromatography: avoiding hydrolytic degradation","volume":"582","author":"Eriksson","year":"1992","journal-title":"J Chromatogr"},{"key":"10.1016\/j.trsl.2007.05.003_bib15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/chir.530070109","article-title":"Sterospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enanthiomers of thalidomide","volume":"7","author":"Eriksson","year":"1995","journal-title":"Chirality"},{"key":"10.1016\/j.trsl.2007.05.003_bib16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1373\/clinchem.2003.022459","article-title":"The interleukin-6 G(-174) C promoter polymorphism does not determine plasma interleukin-6 concentrations in experimental endotoxemia in humans","volume":"50","author":"Endler","year":"2004","journal-title":"Clin Chem"},{"key":"10.1016\/j.trsl.2007.05.003_bib17","unstructured":"Hastings RC Leprosy. 137 1993194 Churchill Livingstone Edinburgh, UK 155."},{"key":"10.1016\/j.trsl.2007.05.003_bib18","first-page":"35","article-title":"Thalidomide induces imbalances in T-lymphocyte sub-populations in the circulating blood of healthy males","volume":"56","author":"Gad","year":"1985","journal-title":"Lepr Rev"},{"key":"10.1016\/j.trsl.2007.05.003_bib19","first-page":"5","article-title":"Thalidomide\u2019s effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+cells in peripheral blood","volume":"63","author":"Shannon","year":"1992","journal-title":"Lepr Rev"},{"key":"10.1016\/j.trsl.2007.05.003_bib20","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0162-3109(95)00039-7","article-title":"Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, staphylococcal entertoxin A, and purified protein derivative","volume":"31","author":"Shannon","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.trsl.2007.05.003_bib21","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0162-3109(99)00169-1","article-title":"Thalidomide\u2019s ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood","volume":"46","author":"Shannon","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.trsl.2007.05.003_bib22","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.4049\/jimmunol.155.10.5038","article-title":"Effects of recombinant dimeric TNF receptor on human inflammatory responses following intravenous endotoxin administration","volume":"155","author":"Suffredini","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2007.05.003_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0162-3109(99)00041-7","article-title":"Inducer-specific bidirectional regulation of endothelial interleukin-8 produced by thalidomide","volume":"43","author":"Dunzenforfer","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.trsl.2007.05.003_bib24","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/infdis\/172.1.144","article-title":"Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal\/permeability-increasing protein","volume":"172","author":"von der Moehlen","year":"1995","journal-title":"J Infec Dis"},{"key":"10.1016\/j.trsl.2007.05.003_bib25","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1172\/JCI114651","article-title":"The acute spanchnic and peripheral tissue metabolic response to endotoxin in humans","volume":"85","author":"Fong","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/j.trsl.2007.05.003_bib26","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF01741790","article-title":"Effect of anticancer drugs on the release of interleukin-6 in vitro","volume":"34","author":"Hasan","year":"1992","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.trsl.2007.05.003_bib27","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.4049\/jimmunol.178.3.1845","article-title":"Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia","volume":"178","author":"de Kruif","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.trsl.2007.05.003_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(08)60532-5","article-title":"Interleukin-6 biology and medicine","volume":"54","author":"Akira","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.trsl.2007.05.003_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-3083.1981.tb00169.x","article-title":"Inhibition of de novo antibody synthesis by thalidomide as a relevant mechanism of action in leprosy","volume":"13","author":"Shannon","year":"1981","journal-title":"Scand J Immunol"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524407001466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524407001466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T18:10:02Z","timestamp":1683915002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524407001466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S1931524407001466"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2007.05.003","relation":{},"ISSN":["1931-5244"],"issn-type":[{"value":"1931-5244","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}